The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.

doi:10.7150/ijms.56928

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.

International journal of medical sciences - 1 Jan 2021

Dai Shuiping, Ren Pengwei, Ren Jing, Yang Lan, Li Weimin

Abstract excerpt

Background: It has been shown that the prognosis of malignant tumors was closely related to the composition and function of immune system, which was associated with genomic features. However, the prognostic value of peripheral T lymphocyte subsets and its relationship with genomic features in lung cancer has not been analyzed extensively. Therefore, this study was intended to evaluate the relationship between...

Topics

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
DNA Mutational Analysis
ErbB Receptors
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms
Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Male

Middle Aged

Mutation

Neoplasm Staging

Prognosis

Progression-Free Survival

Retrospective Studies

Source

Open in PubMed Open full text

Identifiers

PMID: 33859531
DOI: 10.7150/ijms.56928
PMCID: PMC8040422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.PMID 33859531Read ↗

The Relationship Between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective StudySemantic proximity Read ↗

Analysis of Clinical Implications and Immune Landscape in Prognostic Model based on Immune Cell Signatures for Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read ↗

Identification of immune prognostic signature of lung carcinoma based on Genome-wide immune expression profileSemantic proximity Read ↗

Prognostic significance of the peripheral blood CD4/CD8 ratio in lung cancer patients: A meta-analysisSemantic proximity Read ↗

The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancerSemantic proximity Read ↗

Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma of different gendersSemantic proximity Read ↗

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.Semantic proximity Read ↗

Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic modelSemantic proximity Read ↗

Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancerSemantic proximity Read ↗

Lower lymphocyte percentage and higher platelet count as poor prognostic factors for patients with epidermal growth factor receptor–mutated lung adenocarcinoma receiving tyrosine kinase inhibitors as first-line treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.